Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
23.37
+0.61 (2.68%)
At close: May 9, 2025, 4:00 PM
22.99
-0.38 (-1.63%)
After-hours: May 9, 2025, 7:40 PM EDT
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$2,953,845
Profits / Employee
$1,090,337
Market Cap
2.85B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CPRX News
- 1 day ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 9 days ago - Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025 - GlobeNewsWire
- 17 days ago - Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025 - GlobeNewsWire
- 4 weeks ago - Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals - GlobeNewsWire
- 6 weeks ago - Strong Revenue, Drug Performance Lift Catalyst Shares - FXEmpire
- 2 months ago - Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts - Seeking Alpha
- 2 months ago - Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference - GlobeNewsWire